Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 377, Issue 19, Pages 1824-1835
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2017-09-11
DOI
10.1056/nejmoa1709030

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.